ABILIFY MAINTENA (aripiprazole) is indicated for: Treatment of schizophrenia in adults (see Pharmacology: Pharmacodynamics: Clinical Studies: Schizophrenia under Actions).
Maintenance monotherapy treatment of bipolar I disorder in adults (see Pharmacology: Pharmacodynamics: Clinical Studies: Bipolar I Disorder - Maintenance Monotherapy under Actions).